Will This New GLP-1 Drug be More Powerful Than Ozempic?
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
Looking to buy weight-loss jabs? You need to pass more checks from now on
New industry rules require visual size checks or GP medical records for online fat jab purchases. The updated guidelines ...
BioSpace4h
UK Pharmacies Regulator Wants Tighter Checks on Weight Loss Injections
Amid growing concern of the overuse and misuse of obesity drugs, the UK’s pharmacies regulator rolled out stricter guidelines ...
Weight loss jabs hit with stricter rules as people with eating disorders get online prescriptions
The General Pharmaceutical Council (GPhC) has introduced new rules for weight-loss jabs, such as Wegovy and Mounjaro, in ...
'Food controlled me and my GP dismissed it so I turned to weight loss jab Mounjaro'
Lana Hart, 29, has given a searingly honest account about why she turned to weight loss injection Mounjaro amid a national ...
INSIDER on MSN13d
A woman regained weight after she stopped taking semaglutide. Now she works 2 jobs to afford it.
A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...
An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
National clampdown on weight loss jabs like Wegovy amid fears Brits are abusing them
General Pharmaceutical Council issues new guidance following reports people are lying about their weight in online forms and submitting photos of themselves in baggy clothes ...
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...
Hosted on MSN1d
Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?
Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...
What you need to know before considering weight loss jabs, as pharmacists issue fresh warning
NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...